Assistant/Associate Professor
The News Review:
- Assistant/Associate Professor
- omnicomm Systems Signs Licensing Deal with West Coast Clinical …
- Science and Pseudoscience in Adult Nutrition Research and Practice
- Firm seeks volunteers for clinical trials
- Post-stroke depression recovery improved by adding brief …
- Threshold Pharmaceuticals Reports Second Quarter 2009 Financial …
Assistant/Associate Professor
Nature.com (subscription)
The successful candidate will have modern laboratory space located in the newly opened Center for Life Science Building. Joint appointments in the Program in Genomics at Children?s Hospital and the Broad Institute of MIT and Harvard may be available for appropriate applicants. The Division resides within a very strong research and clinical community in genetics developmental biology and related disciplines throughout the Harvard Longwood Medical Area and offers many teaching and clinical opportunities. The Clinical Scientist will hold both Children?s Hospital Boston and Harvard Medical School faculty appointments.
omnicomm Systems Signs Licensing Deal with West Coast Clinical …
PR Newswire (press release) (press release)
(TCBulletinBoard: MCM) a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that it has entered into a licensing agreement with a west coast Clinical Research rganization (CR) for the use of their TrialMaster(TM) solution in a Technology Transfer model. The agreement is expected to generate more than $1. 1 million from licensing maintenance hosting and consulting fees for mniComm over the next three years. It also allows this leading CR to expand its offering to its customers to include the latest in cutting edge technologies for electronic data capture. “We are extremely pleased to have been selected by this new client and we believe that our unique platform of eClinical solutions is being recognized within the clinical research community as a valuable and important tool for facilitating the development of life-saving drugs and devices” said Stephen Johnson mniComm’s C.
Related from Murtoughsupply: Take that West Coast
Science and Pseudoscience in Adult Nutrition Research and Practice
Skeptical Inquirer
Doctors know that clinical research rarely advances in one giant leap; instead it advances incrementally. ”23 The editors did not blame themselves (and other editors) for publishing low-quality or uninterpretable papers. Instead the editors blamed the media which should “improve the way they interpret science. ” Angell and Kassirer then stated that “the public at large needs to become much more sophisticated about clinical research particularly epidemiology” because “what medical journals publish is not received wisdom but rather working papers. ”23Thus they as journal editors placed the burden on the student nutritionist medical scientist physician public and media to determine what is valid important and meaningful sometimes with the help of editorials.
Firm seeks volunteers for clinical trials
East Brunswick Sentinel
(ACCRINC) an independent clinical research site dedicated to full-service care is looking for volunteers for its clinical trials. Trials that are available now are: osteoarthritis and rheumatoid arthritis; migraine; menstrual migraine; osteoporosis; fibromyalgia; and hypertension and flu vaccine according to Melissa Cardillo M.
Post-stroke depression recovery improved by adding brief …
7thSpace Interactive (press release)
Becker professor of neurology; Ann Buzaitis nurse UW Medical Center Neurology Clinic; Kevin C. Cain research scientist Biostatistics; Michael Fruin nurse practitioner and clinical faculty member School of Nursing; David Tirschwell associate professor of neurology; and Linda Teri interim chair and professor of psychosocial and community health and director Northwest Research Group on Aging. The National Institute of Nursing Research a component of the National Institutes of Health funded the research. # # # The University of Washington School of Nursing is consistently the nation’s No. 1-ranked nursing school according to U. News & World Report.
Threshold Pharmaceuticals Reports Second Quarter 2009 Financial …
GlobeNewsWire (press release) (press release)
A webcast presentation of the clinical trial results can be found on the Company’s website. n August 4 TH-302 clinical trial results were presented at the World Congress on Lung Cancer Meeting. The presentation by Dr. Glen Weiss Director of Thoracic ncology at the Virginia G. Piper Cancer Center’s Scottsdale Clinical Research Institute summarized results from two Phase 1 clinical trials of TH-302. The two clinical trials are both evaluating the safety and preliminary efficacy of TH-302 in patients with advanced solid tumors; one in combination with other chemotherapy agents and the other with TH-302 as monotherapy. Data from these trials were previously discussed at the ASC Meeting in May 2009.
Written by admin on August 7th, 2009 with
no comments.
Read more articles on News.